Dyne Therapeutics Inc (DYN)
23.99
-0.31
(-1.28%)
USD |
NASDAQ |
Dec 20, 16:00
25.18
+1.19
(+4.96%)
After-Hours: 20:00
Dyne Therapeutics Total Liabilities (Quarterly): 63.30M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 6.609B |
| Regenxbio Inc | 217.70M |
| Avidity Biosciences Inc | 137.39M |
| Catalyst Pharmaceuticals Inc | 111.07M |
| Sarepta Therapeutics Inc | 2.379B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 768.84M |
| Shareholders Equity (Quarterly) | 705.54M |